Clinical Trial Update: An Observational, Retrospective, UK & Ireland Audit of Patient Adherence to Rebif® Injections Using the RebiSmart™ Injection Device

View source ↗

Summary

This completed observational retrospective audit in the UK & Ireland evaluated patient adherence to Rebif injections when using the RebiSmart device for Relapsi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Multiple Sclerosis

Drugs mentioned

• Rebif (interferon beta-1a)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Relapsing Multiple Sclerosis | Status: COMPLETED